Akso Health Ownership
| AHG Stock | USD 1.26 0.04 3.28% |
Shares in Circulation | First Issued 2016-06-30 | Previous Quarter 440.1 M | Current Value 71.5 M | Avarage Shares Outstanding 42.5 M | Quarterly Volatility 77.8 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Akso |
Akso Stock Ownership Analysis
The book value of the company was presently reported as 0.95. The company recorded a loss per share of 0.21. Akso Health Group last dividend was issued on the 1st of August 2018. The entity had 1:3 split on the 24th of August 2020. Akso Health Group operates a social e-commerce mobile platform in China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited. Akso Health operates under Credit Services classification in the United States and is traded on NASDAQ Exchange. It employs 113 people. For more info on Akso Health Group please contact Yilin Wang at 86 15 2100 54919 or go to https://www.ahgtop.com.Besides selling stocks to institutional investors, Akso Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Akso Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Akso Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Akso Health Quarterly Liabilities And Stockholders Equity |
|
Akso Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Akso Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Akso Health Group backward and forwards among themselves. Akso Health's institutional investor refers to the entity that pools money to purchase Akso Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-12-31 | 139.4 K | Millennium Management Llc | 2024-12-31 | 18 K | Geode Capital Management, Llc | 2024-12-31 | 15 K | Rhumbline Advisers | 2024-12-31 | 14.3 K | Geowealth Management Llc | 2024-12-31 | 7.5 K | Ubs Group Ag | 2024-12-31 | 6.3 K | Blackrock Inc | 2024-12-31 | 1.8 K |
Akso Health Group Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Akso Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Akso Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Akso Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Monast William E over two months ago Disposition of 429 shares by Monast William E of Akso Health at 19.38 subject to Rule 16b-3 | ||
Higby Lawrence M over three months ago Acquisition by Higby Lawrence M of 40000 shares of Akso Health at 16.9375 subject to Rule 16b-3 | ||
Higby Lawrence M over three months ago Disposition of 25000 shares by Higby Lawrence M of Akso Health at 30.4152 subject to Rule 16b-3 | ||
Anido Vicente Jr over three months ago Acquisition by Anido Vicente Jr of 6000 shares of Akso Health at 30.27 subject to Rule 16b-3 | ||
Higby Lawrence M over a year ago Disposition of 50000 shares by Higby Lawrence M of Akso Health at 15.5 subject to Rule 16b-3 | ||
Higby Lawrence M over a year ago Acquisition by Higby Lawrence M of 30100 shares of Akso Health at 0.001 subject to Rule 16b-3 |
Akso Health Outstanding Bonds
Akso Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Akso Health Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Akso bonds can be classified according to their maturity, which is the date when Akso Health Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US98420EAB11 Corp BondUS98420EAB11 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| XEROX HLDGS P Corp BondUS98421MAB28 | View | |
| XEROX HLDGS P Corp BondUS98421MAA45 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Currently Active Assets on Macroaxis
When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akso Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akso Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.21) | Revenue Per Share | Quarterly Revenue Growth 0.148 | Return On Assets | Return On Equity |
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akso Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akso Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akso Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.